Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Annual, J.P. Morgan
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to present at the 43rd Annual J.
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here. OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large,
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Frontier Medicines Corporation ("Frontier" or the "Company"), a clinical-stage precision medicine company unlocking to advance transformational therapies, today announced that Chris Varma, Ph.D., Frontier's co-founder,
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
To access the live webcast or subsequent archived recording of the company presentation, please visit the RAPT Therapeutics website at About RAPT Therapeutics, Inc. RAPT Therapeutics is a clinical-stage,
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, beginning at approximately 9:45 a.
Element Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced that Element CEO and co-founder Molly He will be presenting a corporate update at the 43rd annual J.
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived toolbox. Metagenomi is harnessing the power of metagenomics,
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on ...
Emergent BioSolutions (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced
Modern Healthcare
1d
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...
Commercial Observer
2d
JP Morgan to Order Staff to Return to Offices Five Days a Week
J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...
3d
on MSN
This J.P. Morgan Analyst Is Upbeat About Google. The Stock Is Up.
J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...
BioSpace
1d
Biopharma Heads to JP Morgan Seeking an M&A Spark to Improve Sentiment
M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...
Institutional Investor
1d
J.P. Morgan’s Michael Cembalest Predicts Trump “Alchemists” Will Prompt a Correction in 2025
J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...
6d
on MSN
Carvana Stock Falls. J.P. Morgan and Others Defend Used-Car Retailer From Short Report.
Carvana fell again Friday a day after short-seller Hindenburg Research criticized the used-car retailer in an extensive ...
Pensions&Investments
2d
J.P. Morgan Asset Management bolsters retirement team with former Vestwell, Smart USA execs
Josh Forstater has joined J.P. Morgan Asset Management as managing director, head of Everyday 401 (k), a retirement plan ...
Eagle-Tribune
1d
GlycoNex to Participate in Biotech Showcase 2025 During J.P. Morgan Week
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced today announced its ...
2d
Nvidia In Focus: CES This Week, J.P. Morgan Healthcare Conference Next Week, February Earnings
Then, next week, Nvidia is on the road again at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, which ...
3d
Novo Nordisk (0QIU) Gets a Buy from J.P. Morgan
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback